Navigation Links
U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation
Date:5/23/2013

New York, New York (PRWEB) May 23, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices and drugs, is proud to announce that Senior Litigation Counsel Matthew J. McCauley has been appointed Co-Lead Counsel in the Mirena IUD multidistrict litigation entitled In Re: Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, which was filed on May 22nd, states that Co-Lead and Liaison Counsel are to submit their proposal for the Court’s appointment of a Plaintiff’s Steering Committee by June 17, 2013. U.S. District Judge Cathy Seibel issued the Order.

Mr. McCauley also co-chairs the American Association for Justice (AAJ) Mirena IUD Litigation Group. The Group exchanges educational material and medical literature to help the members best represent victims.

The federal MDL centralizes Mirena lawsuits at the U.S. District Court for the Southern District of New York. Plaintiffs in the litigation allege that the Mirena IUD contraceptive device has caused serious injuries, including uterine perforation; they are suing Bayer, the manufacturer of Mirena, for allegedly failing to warn about the risks.

Parker Waichman LLP is representing numerous women in Mirena IUD lawsuits across the country. One of the firm’s recent cases was filed on April 12th in the Morris County Civil Division in New Jersey (Civil Action No. L1006-13). The lawsuit was filed on behalf of a woman who underwent laparoscopic surgery after the Mirena IUD allegedly perforated her uterus.

Mirena, which was approved in 2000, is a t-shaped intrauterine device that is attached to two strings. According to the U.S. Food and Drug Administration (FDA), the most serious side
effects associated with the Mirena IUD include:

  • Perforation of the uterine wall
  • Embedment of the device in the uterine wall
  • Intrauterine pregnancy
  • Ectopic pregnancy
  • Group A streptococcal sepsis
  • Pelvic inflammatory disease (PID)
(http://www.fda.gov/newsevents/newsroom/pressannouncements/2009/ucm184747.htm)

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Mirena IUD birth control. If you or a loved one experienced complications following the use of this device, please visit the firm's Mirena® IUD Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Contact:    
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/mirenaiud-lawsuits/052013/prweb10764718.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stryker Rejuvenate Attorneys at Kershaw, Cutter & Ratinoff Push for Cases to be Consolidated and Fought in U.S. District Court in Chicago, Illinois
2. Marler Clark, Family of Canadian Woman Sue California Lettuce Supplier in U.S. District Court
3. Federal DuPont C8 Lawsuits Transferred to U.S. District Court, Southern District of Ohio, Alonso Krangle LLP Reports
4. Healdsburg District Hospital Brings Cutting-Edge Fluoroscopic Imaging to North Sonoma County Residents
5. Quality Associates to Digitize Confidential Case Files for the District of Columbia Courts
6. Pharmaceutical companies: An $84 million marketing effort in the District of Columbia
7. MSSD Approves of the Encinitas School District’s Holistic Education
8. d'Oliveira & Associates Notes the Announcement of Zoloft Birth Defects Multidistrict Litigation (MDL) Set to Start in Mid-September 2014
9. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
10. Physician Director of ICU Honored for Innovative Telemedicine Program at Healdsburg District Hospital
11. Nassau County’s Special Districts and Service Providers Mapped for the First Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take ... an inventor from Austin, Texas, has identified a solution. , She developed a prototype ... restricted lighting. As such, it eliminates the need to turn on a light when ...
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: